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Abstract
Background: Cardiomyopathy syndrome (CMS) is a disease associated with severe myocarditis primarily in adult
farmed Atlantic salmon (Salmo salar L.), caused by a double-stranded RNA virus named piscine myocarditis virus
(PMCV) with structural similarities to the Totiviridae family. Here we present the first characterisation of host
immune responses to CMS assessed by microarray transcriptome profiling.
Results: Unvaccinated farmed Atlantic salmon post-smolts were infected by intraperitoneal injection of PMCV and
developed cardiac pathology consistent with CMS. From analysis of heart samples at several time points and
different tissues at early and clinical stages by oligonucleotide microarrays (SIQ2.0 chip), six gene sets representing
a broad range of immune responses were identified, showing significant temporal and spatial regulation.
Histopathological examination of cardiac tissue showed myocardial lesions from 6 weeks post infection (wpi) that
peaked at 8-9 wpi and was followed by a recovery. Viral RNA was detected in all organs from 4 wpi suggesting a
broad tissue tropism. High correlation between viral load and cardiac histopathology score suggested that
cytopathic effect of infection was a major determinant of the myocardial changes. Strong and systemic induction
of antiviral and IFN-dependent genes from 2 wpi that levelled off during infection, was followed by a biphasic
activation of pathways for B cells and MHC antigen presentation, both peaking at clinical pathology. This was
preceded by a distinct cardiac activation of complement at 6 wpi, suggesting a complement-dependent activation
of humoral Ab-responses. Peak of cardiac pathology and viral load coincided with cardiac-specific upregulation of T
cell response genes and splenic induction of complement genes. Preceding the reduction in viral load and
pathology, these responses were probably important for viral clearance and recovery.
Conclusions: By comparative analysis of gene expression, histology and viral load, the temporal and spatial
regulation of immune responses were characterised and novel immune genes identified, ultimately leading to a
more complete understanding of host-virus responses and pathology and protection in Atlantic salmon during
CMS.
Background
Cardiomyopathy syndrome (CMS) is a severe cardiac
disease affecting Atlantic salmon (Salmo salar L.). Since
its first diagnosis in Norway 1985 [1], it has also been
diagnosed in sea farms in Scotland, the Faroe island,
Denmark and Canada [2]. CMS primarily affects farmed
fish from 12 to 18 months after transfer to sea water
[3,4], but cases of CMS in wild salmon have also been
observed [5].
The diagnosis of CMS is based on cardiac histopathol-
ogy, characterised by severe inflammation and necrosis
of the spongy myocardium of the atrium and ventricle
[6]. Inflammatory infiltrates consist of mononuclear
cells, probably lymphocytes and macrophages. The com-
pact layer of the ventricle is usually less affected, and
always occurs later than changes in the spongious layer
[6,7]. Farmed salmon suffering from CMS often lack
clinical signs and may die suddenly due to rupture of
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nade [1,6]. Other symptoms like skin haemorrhages,
raised scales and oedema have also been reported [3,5].
At necropsy, ascitic fluid, fibrinous perihepatitis and
blood clots on the liver and heart are typical findings
[3,5,6]. The first study indicating a transmissible nature
of the disease, showed typical cardiac lesions in salmon
post-smolts six weeks post injection of cardiac and kid-
ney homogenate from CMS-diseased fish [7].
Recently a novel virus associated with CMS was cul-
tured and identified [8]. The proposed virus named pis-
cine myocarditis virus (PMCV) is a double-stranded
RNA virus with structural similarities suggesting assign-
ment to the Totiviridae family. In this study, viral RNA
could be detected by quantitative real-time RT-PCR
(qPCR) from 2 weeks post challenge, peaking at 6-8
weeks post challenge, coinciding with the increase of
histopathological lesions in the heart. Virus particles
were also detected by in situ hybridization in degenerate
and necrotic cardiac myocytes from field outbreaks of
CMS.
In the present study, the same PMCV inoculum was
used to experimentally reproduce CMS and to charac-
terise the host immune response in infected salmon
post-smolts. To gain an understanding of the immune
response and host-virus interaction, a genome-wide
approach based on oligonucleotide microarrays was
used [9]. Six gene sets representing different arms of the
immune response were identified, and temporal and
spatial regulation was evaluated in combination with
histology and relative quantification of viral RNA. The
findings provide a comprehensive understanding of the
immune response against PMCV in Atlantic salmon,
and pathological and protective correlates thereof.
Results
Experimental CMS infection
No mortality or clinical signs associated with CMS was
observed. Potential contamination by other pathogens
was excluded by qPCR for known viruses and bacteria
from relevant organs and numbers of samples. Histo-
pathological examination of heart was scored 0-3
according to severity of CMS lesions, as summarised in
Figure 1. Results were used for evaluation of the infec-
tion challenge and for design of gene expression ana-
lyses. In control groups, one fish had moderate to severe
cardiac lesions at 10 wpi, and was graded score 2 in the
spongy layer of the ventricle and score 3 in the atrium.
For all the other control fish, only score 0 and 1 were
observed. No statistical difference between replicate con-
trol groups was found.
Groups receiving PMCV inoculum developed cardiac
lesions consistent with CMS from 6 wpi and onwards.
At 6 wpi, 63% of the infected fish had moderate lesions
(score 2) in the atrium (percentages refer to observa-
tions, excluding missing values). Lesions were first
found in the atrium and subsequently in the spongy
layer of the ventricle. The peak of histopathological
lesions was observed at 8 wpi, with moderate atrial
lesions (score 2) in 36%, and severe lesions (score 3) in
32% of the fish. In the subsequent time points, fewer
fish had cardiac lesions, and at 9, 10 and 11 wpi, respec-
tively 7.4%, 4.3% and 3.8% of the fish were scored 3. At
12 wpi, only mild focal lesions (scores 0 and 1) were
described in the atrium and spongy ventricle. In general,
lesions were first found in the atrium and were more
severe than in the spongious layer. Differences between
group 3 and 4 were significant for atrial lesions at 10
wpi and epicardial lesions at 11 wpi. Lesions in atrium
of control groups 1 and 2 versus infected groups 3 and
4 were statistically different for all time points except 12
wpi, with highest significance between 4 and 11 wpi (p
< 0.01). A similar difference was found in spongious
lesions with highest significance between 6 and 11 wpi.
Lesions in epicardium differed significantly between
infected and controls at 4, 6 and 9 wpi.
Viral load
PMCV levels were analysed by qPCR to document viral
replication in heart during infection and in the different
tissues at early infection (4 wpi) and peak pathology (8
wpi) stages (Figure 2). The same six individuals per time
point as used for gene expression analyses were tested.
Since 0 wpi and the two latest time points (11 and 12 wpi)
w e r en o ti n c l u d e di nm i c r o a rray analysis, six randomly
chosen samples from group 3 and 4 were tested respec-
tively. At 2 wpi, 5 out of 6 fish were positive for viral RNA
in heart (median of relative copy number = 20.5 fold, Fig-
ure 2a). Levels increased strongly until 4 wpi and then gra-
dually until 6 wpi (median of relative copy number = 11,
583 fold), concurrent with the onset of histopathological
changes. Levels reached a plateau phase between 6 and 10
wpi with no significant changes in viral RNA. From 10 to
11 wpi, levels were significantly reduced, indicating a
clearance of virus. One week later (12 wpi), both viral load
and individual variance were reduced. For most time
points, individual variation in viral RNA was observed,
analogous to the variation observed for histopathology
score. Correlation between histopathology scores and viral
CT levels in heart was highly significant (correlation coeffi-
cient: 0.75, p = 5.5 × 10
-11) (Figure 3).
Comparison of viral loads between tissues showed
highest and equal viral loads in heart, spleen and kidney
(Figure 2b). Significantly lower and equal levels of viral
RNA were found in blood cells (PBL and RBC) and
liver. Except for heart (p = 0.030), viral loads were not
significantly different between 4 and 8 wpi in any of the
tissues investigated.
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pathways
The main purpose of the gene expression study was to
identify gene sets representing different immune path-
ways and characterise their regulation over the time
course of CMS in the infected organs. Fish were chal-
lenged by injection to ensure simultaneous infection and
virus dose. Since histomorphological changes were
investigated in cardiac tissue, RNA from infected versus
control heart samples from six time points (2, 4, 6, 8, 9
and 10 wpi) were used for microarray analysis. In order
to examine responses in fish with similar disease status
and infection level, individuals with highest histology
scores and viral loads were selected from the time
points when pathological changes were significant (6-10
wpi). After microarray experiments, 5712 differentially
expressed genes with a mean log2-ER > |0.65| in at least
one time point were selected. Genes implicated in differ-
ent immune pathways were defined in the resulting list
using the STARS software package [9], which contains
custom annotation of genes on the microarray based on
GO classes, KEGG pathways, mining of literature and
public databases and experimental evidence (transcrip-
tion profiles/meta-analysis). Further, immune genes
were arranged in seven sets taking into account both
functions and the expression profiles. Six gene sets
(Additional file 1) showed differential expression
between at least two subsequent time points (one-way
ANOVA with Newman-Keuls test, Additional file 2),
while one gene set (inflammatory components) was
excluded since no significant temporal changes were
found. The log2-ER for all genes per gene set and time
point were combined from microarray results of the two
sample pools (2, 6, 9, 10 wpi) and four sample pools (4
and 8 wpi). The resulting expression profiles of the six
gene sets are shown as box plots in Figure 4. Gene com-
position and temporal regulation for each gene set is
presented in the following section.
Composition and temporal regulation of immune
pathways
1: Early antiviral and interferon response
This gene set included 85 genes associated with nonspe-
cific innate immunity related to the early antiviral and
interferon (IFN) responses. This also included predicted
pattern recognition receptors (e.g. toll-like receptors and
RIG helicases) and associated genes, and early induced
virus-responsive genes known from other salmonid viral
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Figure 1 Cardiac histopathology results of PMCV infected and control groups. The proportions of histopathology scores in atrium (A),
epicard (E) and spongious (S) were plotted as percentage bars. The bars represent the results of the 15 sampled fish per group and time point.
The histopathology scores are shown as colours from green (score 0) to red (score 3), grey indicates missing tissue. Asterisks in the middle row
represents the level of significance between groups (*/** = p < 0.05/0.01), according to two-sided t-tests. The row in the middle represents the
difference between the two infected groups and the two control groups.
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masome/pyrin-like genes such as VHSV-induced and
TRIM/RING finger genes). The expression profile
showed strongest upregulation at the early stages which
levelled off during infection (Figure 4a). A median log2-
ER +2.1 at 2 wpi decreased to +0.7 at 6 wpi. This level
remained unchanged until 9 wpi followed by a signifi-
cant decrease to +0.5 at 10 wpi. A heat map showing
t h ee x p r e s s i o no ft e ng e n e si sg i v e ni nF i g u r e5 .T h e s e
were selected either by random or based on their func-
tional importance as evidenced from other studies in
fish or higher vertebrates. Early upregulation of the
cytoplasmic RNA helicases retinoic acid inducible gene I
(rigI)a n dmelanoma differentiation-associated gene 5
(mda5)i n v o l v e di ns e n s i n ga n dd e g r a d a t i o no fv i r a l
RNA, as well as a gene similar to the membrane-bound
toll-like receptor 3, implied activation of virus recogni-
tion receptors and antiviral signalling. Several genes
known to be activated in response to IFN signalling
were upregulated, such as signal transducer and
activator of transcription 1a (stat1a), myxovirus resis-
tance gene Mx, interferon-inducible protein Gig2-like and
radical s-adenosyl methionine domain-containing protein
2 (rsad2)a l s ok n o w na sviperin. A similar expression
profile was also observed for a suit of genes known to
be induced by IFN but with unknown roles in fish
immunity, such as interferon-induced protein with tetra-
tricopeptide repeats 5 (ifit5)a n dvery large inducible
GTPase 1 (vlig1). A transcript encoding the 52 kDa Ro
protein was one of several TRIM/RING finger genes
highly induced at 2 and 4 wpi, supporting the role of
this multi-gene family in early virus recognition and
host defence [10].
2: Complement response
Twenty-two genes associated with the complement sys-
tem were not differentially regulated at 2 wpi followed
by a gradual upregulation from 4 wpi which peaked at 6
wpi (median log2-ER +1.5), concurrent with the onset of
cardiac pathology. In subsequent time points expression
levelled off, with a weak but significant induction at 9
wpi coinciding with pathology peak (Figure 4b). The
upregulation at 6 wpi was significantly stronger com-
pared to earlier and later time points. The heat map of
representative genes (Figure 5) shows activation of genes
with different roles in the complement system: Antigen:
antibody-complex binding by C1q; activating enzymes
C2b and C1r/s; membrane-binding proteins and pep-
tide-inflammatory mediators C3a/4a/5a, C3, C3-4 and
C5 pre-protein; and membrane-attack protein by C8b.
Figure 2 Assessment of viral load by qPCR.( a )T i m ec o u r s e
study in heart tissue: PMCV levels are shown as relative copy
numbers for six individuals per time point. Copy numbers are
relative to the median of the 0 wpi values which was set to 1. The
black lines show the variance and blue bars represent the median.
(b) PMCV levels in different tissues at 4 and 8 wpi. Relative copy
numbers are shown as green dots (4 wpi) or red dots (8 wpi).
Numbers are relative to median of 0 wpi values set to 1 (a). Levels
of significant differences (t-test) were calculated for log-transformed
values.
Figure 3 Correlation between cardiac histopathology and viral
loads. Histopathology scores were correlated against relative copy
numbers of PMCV in infected fish (n = 6) from all time points. Data
points are plotted randomly across the box area in x-direction for
better visualization. Correlation coefficient and p-value were
calculated for log-transformed copy numbers.
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Page 4 of 17Figure 4 Temporal regulation of immune responses in PMCV infected fish. Box plots show log2-ER (expression ratios) for all genes included
in the six gene sets (a-f) resulting from microarray analysis of infected versus control fish from the time course study in cardiac tissue. Boxes
represent 50% of the values, while black bars mark the median log2-ER. Whiskers indicate the maximum length of 1.5 times the box length.
Values beyond whiskers are plotted as circles. Significance levels of t-tests between time points are coded with asterisks: * = p-values between
0.01 and 0.05, ** = p-values < 0.01.
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28: Tyrosine-protein kinase Lyn [Salmo salar] 
29: Immunoglobulin mu heavy chain [Oncorhynchus mykiss] 
30: CD9 antigen [Salmo salar] 
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31: Minor histocompatibility antigen HA-1 [Homo sapiens] 
32: HLA class II histocompatibility antigen gamma chain [Salmo salar] 
33: Proteasome activator complex subunit 1 [Salmo salar] 
34: Cathepsin S precursor [Salmo salar] 
35: TAP2b [Salmo salar] 
36: Proteasome subunit alpha type-7 [Salmo salar] 
37: PSMB9b-like protein [Salmo salar] 
38: AF504025_1 MHC class I [Salmo salar] 
39: Beta-2-microglobulin precursor [Salmo salar] 
40: AF115537_1 TAP2 protein [Oncorhynchus mykiss] 
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41: Interferon, gamma [Salmo salar] 
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43: T-cell receptor beta chain T17T-22 precursor [Salmo salar] 
44: CD4 T-cell surface glycoprotein 
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51: Regulator of G-protein signaling 1 [Salmo salar] 
52: CD265 Tumor necrosis factor receptor superfamily member 5 precursor 
53: Rho-related GTP-binding protein RhoG precursor [Salmo salar] 
54: Programmed cell death protein 4 [Salmo salar] 
55: CDC42 small effector 2 [Homo sapiens] 
56: Rho GTPase-activating protein 15 [Salmo salar] 
57: Programmed cell death 1 ligand 1 precursor [Salmo salar] CD274 
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Figure 5 Temporal regulation of representative genes. Heat map showing the temporal expression of ten selected genes from each
immune pathway (gene set) from Figure 4, as referred to in the Results section. Data are mean log2-ER of replicate pools of heart tissues from
the six time points (2 to 10 wpi). Graded levels from gray to red indicate upregulation, and graded levels from gray to blue indicate
downregulation. The scale of the colors is shown at the bottom of the figure.
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Page 6 of 173: B cell response
This gene set included 37 genes involved in differentia-
tion and regulation of B cells and antigen recognition by
immunoglobulins. The expression profile was charac-
terised by upregulation at two time points; during early
infection 4 wpi and at peak pathology 9 wpi (Figure 4c).
The later peak was stronger with median log2-ER +0.93
compared to +0.57 at 4 wpi. The two peaks were sepa-
rated by the complement activation at 6 wpi. Immuno-
globulin-related genes, represented with 21 distinct
transcripts, comprised a large part of this group (Addi-
tional file 1). Genes related to antigen receptor signal-
ling included hematopoietic lineage cell-specific (Lyn
substrate 1) protein (hs1) and kelch-like protein 6 (klhl6)
(Figure 5). Similar function was predicted for several
genes with Src homology-3/2 (Sh3/2) domains and
activities, such as src kinase-associated phosphoprotein 2
(skap2)a n ddual adapter for phosphotyrosine and 3-
phosphotyrosine and 3-phosphoinositide (dapp1). The
tyrosine-protein kinase lyn also plays a regulatory role in
B cell receptor response after antigen binding. The CD9
antigen, which is expressed in many B cell subsets and
in plasma cells in mammals [11,12], was strongest
induced at the early peak. The opposite was found for
CD97 antigen precursor, suggesting that it may have a
role in activated B and T cells.
4: MHC antigen presentation
This gene set included 34 genes involved in processing
and presentation of viral antigens via MHC class I and II.
The expression profile was similar to that of B cell
response, but with less difference in average induction
levels between the two peaks at 4 and 9 wpi, respectively
log2-ER +1.09 and +1.21 (Figure 4d). Besides, these genes
were significantly upregulated already at the earliest time
point (2 wpi). The gene set was dominated by genes
related to the MHC class I pathway, such as antigen pro-
cessing by proteasome components PSMBs/TAPs, and
antigen presentation by the MHC class I heavy chain and
light chain beta-2-microglobulin (Figure 5). Examples of
MHC class II related genes were a salmon homologue to
the HLA class II histocompatibility antigen gamma chain
and cathepsin s precursor, a lysosomal cysteine peptidase
involved in degradation of peptides for antigenic presen-
tation on MHC class II molecules [13].
5: T cell response
The fifth gene set included 69 genes with known or pre-
sumed roles in the regulation and effector functions of
T lymphocytes. The expression profile showed a slight
but significant upregulation from 2 to 4 wpi which
increased by additional +1 median log2-ER at 8 wpi and
reached maximum of +1.4 log2-ER induction at 9 wpi
(Figure 4e). This peak coincided with highest levels of
the MHC antigen presentation and B cell response
genes, and the time points when viral load and cardiac
pathology were peaking. From 9 to 10 wpi gene expres-
sion dropped significantly. All classes of effector T cells
seemed to be activated from 8 wpi onwards; cytotoxic
(CTL) cells by induction of interferon gamma, granzyme
and CD8 beta and T helper cells by induction of CD4 T
cell surface glycoprotein (Figure 5). Upregulation of
other genes with common regulatory roles in T cell acti-
vation included CD3 antigens, T cell receptor genes,
CD28 T-cell specific surface glycoprotein and the proto-
oncogene tyrosine-protein kinase lck.
6: Apoptosis
A group of 25 genes functionally linked to apoptotic
pathways showed a coregulated expression pattern with
the T cell response gene set, and was assumed to be
involved in controlling cell death of T lymphocytes and/
or host target cells, as their maximum induction coin-
cided with the histopathology peak (Figure 4f). This
gene set included several genes from the family of TNF
receptors and caspases, with central roles in the execu-
tion phase of apoptosis (Figure 5). Interestingly, the
majority of genes was linked to the family of Rho
GTPases, with recently established roles in controlling T
cell regulation and apoptosis, e.g. rho-related GTP-bind-
ing protein RhoF and G precursors, CDC42 small effector
2, rho GTPase-activating protein 15, regulator of G-pro-
tein signalling 1, and several genes related to the Ras
superfamily (Additional file 1). Other important regula-
tors of programmed cell death in immunity which were
activated included the tnf decoy receptor (tnfrsf6b) and
the programmed cell death 1 ligand 1 precursor CD274.
Tissue regulation of immune pathways
Next, we analysed the tissue-specific features of immune
transcriptome responses during CMS. Two RNA sample
pools (n = 3 each pool, same individuals as analysed in
the time course study) from the same organs as tested
for viral load were analysed by microarrays from two
time points; before the onset of cardiac pathology at 4
wpi and at peak of cardiac pathology/viral load at 8 wpi.
The six gene sets outlined in the time course study were
examined (Additional file 1), and their expression pro-
files are shown as box plots in Figure 6. Early antiviral
and IFN-dependent genes were induced in all tissues,
with significantly higher median log2-ER at 4 wpi com-
pared to 8 wpi (Figure 6a). Levels at 4 wpi were similar
in kidney, heart, spleen and blood, being lower in the
liver. MHC antigen presentation also responded to
infection in all examined tissues and, except for heart,
levels were generally stronger at 4 versus 8 wpi (Figure
6d). The remaining functional groups showed restricted
expression changes. The complement response was
upregulated in spleen at the peak of pathology 8 wpi
(Figure 6b). Genes associated with B cells were upregu-
lated in heart and at both time points (Figure 6c). They
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at 4 wpi and in RBC at 8 wpi. The T cell and apoptosis
gene sets showed similar expression profiles, with induc-
tion in heart which was strongest at peak pathology 8
wpi when compared to 4 wpi (Figure 6e-f). In addition,
a significant though relatively weak increase was found
in RBC between 4 and 8 wpi. Similar to the B cell
response, kidney showed a transient induction at 4 wpi.
Real-time qPCR analyses
To verify the microarray results, six differentially
expressed genes were analysed by qPCR in the four sample
Figure 6 Regulation of immune responses in different tissues.B o xp l o t ss h o wl o g 2-ER (expression ratios) for all genes included in the six
gene sets (a-f) resulting from microarray analysis of infected versus control fish from the study in different tissues and from two time points;
early infection stage (4 wpi) and peak cardiac pathology/viral load (8 wpi). Details on the box plots are described in the legend of Figure 4.
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dent methods were in close concordance (Figure 7). The
coefficient of linear regression was close to unity (0.97)
while correlation and linear dependency were highly sig-
nificant (Pearson r: 0.85, p = 3.8 × 10
-6). The qPCR ana-
lyses also assessed the individual variation and relationship
between viral load and gene expression changes at 4 wpi.
Six genes encoding putative antiviral and IFN-dependent
genes from gene set 1 were selected due to high induction
levels at this early time point. Relative expression of rig-I,
mda5, stat1a, ifit5, rsad2 and baf was determined in 20
individuals from CMS infected groups 3 and 4 versus the
same control pool as used for the microarray experiments
(n = 10) (Figure 8). These genes were strongly induced in
all fish with median fold changes from +3 (mda5)t o+ 5 2 . 5
(baf). At this time point, no significant histopathological
changes were observed, and equal numbers of individuals
had histopathology scores of 0 or 1. As expected, none of
the analysed genes showed significantly different expres-
sion between fish with histopathological scores 0 and 1
(both corresponded to a normal state of heart). Viral load
in heart varied between CT 19-25 in these individuals, and
gene expression levels and virus CT values were strongly
correlated for all six genes (Table 1). This implied that
genes were activated as a result of increased viral
replication and suggested that they might represent mar-
kers of early infection status.
Discussion
This study addressed the temporal and spatial develop-
ment of immune responses assessed by transcriptome
changes during experimental piscine myocarditis virus
infection. The regulation of immune pathways was com-
pared to the disease status evaluated by histopathology
and viral load, aiming at a comprehensive understanding
of the host-virus interactions. These results provide a
framework for in-depth functional studies on immunity
and for evaluation of preventive strategies such as vacci-
nation and nutritional intervention during CMS in
Atlantic salmon.
Challenge trial and infection
Since the discovery of CMS, its diagnosis has been based
on clinical findings and cardiac histopathology [4]. A
virus with structural similarities to the Totiviridae family
named PMCV was recently identified as the presumed
causative agent of CMS [8]. Thus, pathogenesis and dis-
ease progression can now be more thoroughly evaluated
by combining virus-specific qPCR with histology. It
should be noted that due to difficulties with PMCV cul-
tivation in vitro, virus titration has not been successful
yet (M. Rode, personal communication). Consequently,
the relative expression of viral RNA in this study could
not be related to actual numbers of viral particles. Car-
diac histopathology showed moderate to severe lesions
consistent with CMS (score 2 or 3) exclusively in
infected groups, with only one exception in control
groups at 10 wpi. Furthermore, replicate groups were
very similar to each other with respect to histopathology
score. Significant differences between group replicates
were only observed between infected groups at two time
points (atrium at 10 wpi and epicardium at 11 wpi). The
differences between infected and control groups were
mainly associated with lesions in the atrium and spongy
layer of the ventricle, which were highly significant from
4 to 11 wpi and 6 to 11 wpi, respectively. As expected,
no lesions were observed in the compact layer of the
ventricle, and lesions in epicardium were less prominent.
These results are coherent with the pathology as
described from clinical outbreaks and previous challenge
trials with CMS [4,7,8].
After the peak in histology score at 8-9 wpi, lesions
declined gradually suggesting the onset of a recovery
phase. This was supported from qPCR analysis of viral
load which followed the same pattern: increased replica-
tion until 6 wpi followed by a plateau phase until 10
wpi, and finally decreasing levels to the end point of the
challenge trial. Thus, the strong correlation between his-
topathology and viral load which peaked concurrently
Figure 7 Confirmation of microarray results by qPCR. Expression
levels of six genes were compared, as listed in Additional file 4.
Log2-ER from microarrays was plotted on the y-axis, while log2-
transformed fold changes from real-time qPCR were plotted on the
x-axis. The four replicate pools of heart tissue from 4 wpi against
control pools were measured for each gene. The dashed black line
represents the regression function of the measured values. The
function is shown in the top left corner of the plot. In addition, the
Pearson correlation and the corresponding p-value are shown.
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the observed cardiac lesions resulted from virus cyto-
pathic effects and necrosis of infected myocytes, trigger-
ing an inflammatory response followed by activation of
T-cell mediated immunity. Examination of viral loads
across different tissues showed equally high levels of
viral RNA in kidney and spleen as compared to heart,
while liver and blood cells had lower levels. However,
increased replication from 4 to 8 wpi was only observed
in heart, supporting that this organ was the main site of
virus propagation [8]. However, heart may not be the
primary replication site, since viral RNA was detected in
all tissues and blood cells early after infection. High
infection levels in kidney and spleen are typical for viral
diseases in salmon, and are probably related to their
roles in attracting primary infected/antigen presenting
cells and priming lymphocytes for specific immunity.
F r o mac h a l l e n g et r i a lw i t ht h er e c e n t l yd e s c r i b e dp i s -
cine reovirus (PRV) [14], higher viral loads were found
in spleen and kidney as compared to lower but equal
levels between heart and liver [15]. While belonging to
different families, both PRV and PMCV cause necrosis
and inflammation in heart muscle. The lower levels of
PRV in heart may reflect a more persistently infecting
nature compared to PMCV [8,15].
While clinical CMS outbreaks typically give 5-20%
mortality [4], no fish died in the present challenge trial.
This suggested that during natural CMS outbreaks,
either larger fish (or different life stages), higher num-
bers of infectious viral particles or possibly additional
stressors must be present to give mortality. Coherence
between distinct stress factors and viral infection result-
ing in higher mortality has been shown for other dis-
eases in farmed Atlantic salmon [16,17]. An interesting
observation was the high proportion of fish with no or
moderate cardiac lesions at time points when viral loads
and histopathological scores were significant. Thus, fish
obviously exhibited different outcomes of infection.
Comparison of these groups is currently under investi-
gation. In the present study, fish with strongest pathol-
ogy and viral infection were selected at each time point,
in order to characterise immune responses at the tran-
scriptome level in fish at similar stages of the disease
process and with representative CMS pathology. Fish
was challenged by injection to ensure simultaneous
infection of all fish and since cohabitation had shown to
give slower development of disease and weaker overall
pathology ([8] and unpublished results). The individual
qPCR analysis of six antiviral genes in 20 fish 4 wpi
showed similar levels of upregulation, supporting that
all fish had mounted equal antiviral responses following
infection and were in similar disease state. This was
further supported by a significant increase in viral loads
of fish between week 2 and 4.
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Figure 8 Assessment of individual expression of antiviral genes. Gene expression in 20 infected fish (from groups 3 + 4 at 4 wpi) is shown
as fold change relative to uninfected controls based on real-time qPCR. The y-axis is plotted logarithmic. Bars are colored according to the
histopathology score of atrium for respective fish; green = score 0, yellow = score 1. The median fold change for each histopathology score per
gene is indicated with a blue line.
Table 1 Correlation between expression levels of antiviral
genes and viral load.
Gene Correlation coefficient p-value
stat-1a 0.863419 0.001287
rsad 2 0.887746 0.000605
ifit 5 0.854039 0.001659
rig-I 0.909621 0.000261
baf 0.903799 0.000333
mda 5 0.836384 0.002561
mRNA levels (fold change relative to controls, real-time qPCR) of six genes
(from early antiviral and IFN gene set) from 6 individual fish were tested for
correlation (Pearson) against viral loads (non-normalized CT values, real-time
qPCR) at 4 wpi.
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Early antiviral and IFN responses were activated at every
time point and across tissues during infection. However,
the overall expression profile showed declined mRNA
levels with time in spite of increased virus replication.
This contrasted the strong correlation between expres-
sion levels of six selected genes and viral load observed
at 4 wpi, implying that activation of these genes with
increased production of viral RNA was predominant at
the early stage and possibly related to autocrine effects,
such as pathogen recognition and induction of signalling
pathways. The subsequent reduction in transcriptional
activity might be due to increased paracrine effects of
proteins in the induced innate responses, including both
effector functions for clearance of virus and recruitment
of immune cells for development of humoral and adap-
tive immunity. The IFN type I responses to different
viral diseases have been reported in salmonids, with par-
ticular focus on IFN alpha and Mx protein [18-21]. We
identified a suite of putative IFN-dependent genes with
stronger upregulation which have been unknown or
scarcely investigated in salmon. Most of these genes
have shown responses to other viral diseases in salmon
[9]. Strongest induction at 2 wpi was found for ifit5 and
rsad2,a l s ok n o w na sviperin. Both genes are known to
be induced by IFN and involved in defence against
viruses [22,23]. Little is known about gig1-a n dgig2-like
genes in fish, but they were induced by viral infection in
grass carp cells [24]. Members of this gene family were
also strongly induced in rainbow trout 24 h post infec-
tion with the parasite causing whirling disease [25]. Four
different genes from the tripartite motif (TRIM) family
C-IV were also significantly induced over several time
points. One of them, TRIM25, has been implicated in
the RIG-I pathway by regulating the capability of RIG-I
to activate type I IFN [26,27]. Several genes belonging
to families of IFN-inducible GTPases were also early
induced, including two transcript similar to very large
inducible GTPase 1 (VLIG1) and eight transcripts simi-
lar to GTPase IMAP family member 7. The role of
these novel GTPases in vertebrate infection is gaining
interest [28,29].
Proteins of the complement system bind and opsonize
viral particles, marking them for phagocytosis by APCs.
Binding to antigen-antibody complexes makes the com-
plement system a bridge between the innate and the
adaptive immune system. This is in line with results of
the present study, where upregulation of complement
genes at 6 wpi took place shortlya f t e rt h ef i r s ta c t i v a -
tion of B cell- and MHC antigen presentation genes and
the onset of cardiac histopathology. In subsequent time
points, activation of the adaptive immune response was
most prominent. This distinct sequence of immune
events was evidence for a coordinated regulation of
responses, and the ‘bridging’ role of the complement
system between the early innate response and the fully
activated adaptive response. Coincidence with the first
occurrence of moderate cardiac lesions (histopathology
score 2), suggests complement genes as candidates dis-
ease markers for the early clinical stage of CMS.
The immediate activation of antigen presentation as
has been observed during early virus infection in salmon
[19], was supported by the upregulation of proteasome
and MHC class I pathway genes that coincided with the
early IFN/antiviral response at 2 wpi. This was analo-
gous to the typical development of an adaptive immune
response: while IFNs are strongest activated and elicit
antiviral effects very early after infection, they also have
an activating effect on antigen processing and presenta-
tion [30]. Activation of antigen presentation is also the
first step in the cellular immune response mediated by
B and T lymphocytes. The first peak of B cell activity
was detected at 4 wpi following the typical pattern of a
humoral immune response in teleost fish, usually
expected between 4 and 6 weeks after infection [31].
However, the co-regulated B cell- and MHC antigen
presentation genes showed a biphasic expression, with a
second and even stronger activation at 8 and 9 wpi
when the clinical signs were also peaking. This observa-
tion is probably explained by the higher influx of leuko-
cytes and level of inflammatory reactions in heart tissue
as supported by histology. Interestingly, stronger second
peak of induction occurred after the activation of com-
plement genes at 6 wpi. This may indicate that a poten-
tial humoral response based on antibody-dependent
cellular cytotoxicity and virus neutralization is comple-
ment-dependent. Future development of tools for
assessment of virus-specific antibody titers may confirm
this. Most of the representative genes (Figure 5) fol-
lowed the typical regulatory pattern for B cell and anti-
gen presentation components. For example, the
strongest induction of CD9 was found at 2 and 4 wpi,
before the strongest T cell activation was detected. It
has been shown that CD9 is induced downstream of the
antigen receptor during T-independent humoral B cell
response [32]. However, the majority of genes showed
highest upregulation in heart at peak pathology and
viral load, 8 and 9 weeks after infection, indicating their
role in B cell responses and presentation of viral anti-
gens to effector T cells. One example was CD97, a sur-
face protein of both B and T lymphocytes which is
expressed at low levels in inactive cells but rapidly
induced after activation [33]. Thus, it can be used as a
marker of general activation of lymphocytes. In this
study it was a representative marker gene for the overall
expression profile of B/T lymphocyte-related responses.
The co-regulatory pattern of T cell- and apoptosis-
related genes correlating with histopathology score was
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hearts. Control of cell death by apoptosis is a fundamen-
tal process for regulation of the T cell response and for
maintaining homeostasis in the immune system after it
has expanded to combat infections [34]. Importantly,
dysfunctional control of T cell function and apoptosis is
associated with immunopathology [35]. Thus, the apop-
tosis-related profile coinciding with the T cell profile in
this study may represent novel genes involved in regula-
tion of effector function and controlled cell death of T
cells in salmon. Of particular interest were several genes
encoding TNF-related proteins and programmed cell
death ligand 1 (aka B7-H1/CD274). The dominance of
genes encoding Rho GTPases was interesting, since they
have been implicated in the regulation of TCR signaling,
T cell cytoskeletal reorganization, T cell migration and
T cell apoptosis [36]. It seemed to be a borderline from
6 to 8 wpi when expression of T cell/apoptosis pathways
was significantly induced, coinciding with the first
occurrence of histopathology scores 3 and virus CT
values below 20. According to this pattern, the first
severe inflammation and cytopathic effects caused by
the virus (histopathology score 2) at 6 wpi was probably
the priming event for a strong influx of lymphocytes to
the infected heart tissue. Cardiac elevation of mRNA
levels for CD8, granzyme and IFN gamma at 8-10 wpi
indicated activity of cytotoxic CD8
+ T cells. Genes
encoding CD4 were also induced, but at lower levels.
One week after elevation of T cell activity (9 wpi, med-
i a no fr e l a t i v ef o l dc h a n g eo fP M C V=1 0 ,0 2 1 )v i r a l
load and histopathology score were decreasing (10 wpi,
median PMCV fold change = 8, 404), and the first sig-
nificant decrease was evident at 11 wpi (median PMCV
fold change = 983). This indicated that the cellular
effector response mediated by T cells, and in particular
CD8
+ T cells, was contributing to a successful clearance
of the virus infection. Among other interesting genes in
this group, TNF decoy receptor showed the highest cor-
relation versus histopathology score and viral load.
However, the function of this receptor in salmon immu-
nity is not known.
Tissue regulation of immune responses
The systemic induction of early antiviral and IFN-
dependent genes was expected, given the observed repli-
cation of PMCV in all tissues and the fact that most of
these genes are presumably activated in the presence of
viral RNA. The stronger induction at early infection 4
wpi compared to peak viral load 8 wpi was common for
all tissues and blood, and has already been discussed.
The functional relation between IFNs and MHC antigen
presentation pathways was supported by their similar
expression profiles across tissues and time points. The
only exception was the cardiac expression of the latter,
which was equally induced between time points (4 and
8 wpi). Proteasome and MHC components are com-
monly induced by IFNs during viral infection [19,37]. In
addition to heart tissue, where pathology developed,
these genes were equally induced in spleen and kidney
at 4 wpi supporting the importance of these tissues for
lymphocyte maturation and priming of the immune
response [38]. The observation that this induction was
not in sync with viral load may further suggest that
these responses were time-dependent, e.g. related to the
stage of disease rather than viral load and pathology.
Little is known about the expression of complement
components in Atlantic salmon during viral infections.
In common carp and channel catfish, the highest
expression of complement was found in the liver
[39,40]. In humans, liver is also the main source of com-
plement component C3, but production in macrophages
and endothelial cells has also been shown [41]. During
CMS, complement genes were only activated in extrahe-
patic tissue and more specifically in cardiac tissue,
where virus infection was most prominent. Interestingly,
complement genes were induced in the spleen during
clinical phase, suggesting that splenocytes (e.g. macro-
phages) represent an important source of complement
and can play a role in this response in salmonid virus
infection. This induction of complement was also inde-
pendent of viral load, which was equal between 4 and 8
wpi. In humans, the complement component C3 has an
important role in regulating the maturation of B cells in
the spleen [42]. Thus, the induction of splenic comple-
ment might reflect signalling events between activation
of antigen presenting cells such as B cells and possibly
production of virus-specifica n t i b o d i e s .H o w e v e r ,m o r e
research is needed to understand this process. Tissue
regulation of adaptive immune responses as represented
by expression of B cell, T cell and apoptosis gene sets
shared some common features. Most notable was the
opposite regulation of these responses in heart and kid-
ney between the early and clinical stage, which was
characterised by an induced expression from 4 to 8 wpi
in heart, and reduced expression from 4 to 8 wpi in kid-
ney. Interestingly, twelve genes (among them CD8,
CD37, granzyme and TNF decoy receptor) showed no
regulation in heart but induced expression in kidney at
4w p i .O nt h ec o n t r a r y ,a t8w p ii n d u c t i o nw a s
restricted to heart while no expression changes were
found in kidney. This could be evidence for an early clo-
nal expansion and maturation of effector T cells in kid-
ney which then migrated to the heart for elimination of
virus-infected cells four weeks later. The adaptive
immune responses in kidney was activated at the early
stage of infection despite equally high levels of viral
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role for kidney in the early priming and maturation of
cellular immunity.
Conclusions
We used oligonucleotide microarrays to assess transcrip-
tome changes in Atlantic salmon experimentally infected
with PMCV, inducing cardiac pathology consistent with
CMS and transient viraemia. From comparative analysis
of gene expression, histology and viral load, the tem-
poral and spatial regulation of immune responses were
characterised and novel immune genes identified, ulti-
mately leading to a more complete understanding of
host-pathogen responses and pathology and protection
in Atlantic salmon during CMS.
Methods
Experimental infection and sampling
The infection trial was performed at VESO Vikan
(Veterinary Science Opportunities, Namsos, Norway), a
GLP-certified research station for infectious challenge
experiments on aquatic organisms. The trial was
approved by The National Animal Research Authority
http://www.fdu.no according to the ‘European Conven-
tion for the Protection of Vertebrate Animals used for
Experimental and other Scientific Purposes’ (EST 123).
The experimental design with selection of sampling
times and PMCV inoculum was based on results from
two previous pilot trials [7] (and unpublished results).
From both of these experiments, histopathological
lesions associated with CMS were significant from week
6 until week 10 post challenge (injection). Therefore, in
t h ep r e s e n ts t u d yw es a m p l e dw e e k l yf r o m8u n t i l1 2
weeks post challenge, aiming to cover the period with
CMS pathology. Biweekly sampling after infection (2, 4,
6 wpi) was done in order to cover the early phase before
pathology. Unvaccinated Atlantic salmon (Salmo salar
L., standard strain from Aqua Gen AS) were smoltified
(seawater-adapted) according to standard procedures
and kept at 12°C under standardised conditions (light,
feeding, water flow, salinity and fish density). Fish were
acclimatised in respective tanks for at least one week
before challenge.
The trial was conducted in four separated tanks; one
infected and one control group in duplicates. Each tank
contained 120 fish with an average weight of 50 g at the
beginning of the experiment. Injection of PMCV was per-
formed after sedation (benzocaine, 30-40 mg L
-1). Infected
groups received an intraperitoneal (i.p.) injection dose (0.2
ml) of a supernatant from a GF-1 cell line (derived from
the fin tissue of orange-spotted grouper, Epinephelus
coioides [ 4 3 ] )i n f e c t e dw i t hP M C Va sd e s c r i b e d[ 8 ] .I n
short, heart tissue from freshly dead Atlantic salmon was
collected from a clinical field outbreak of CMS (diagnosed
by histopathological examination, score > 3). Tissue was
homogenised, centrifuged to remove cellular debris (4000
g at 4°C for 20 min) and filtrated (0.22 μm filter) before
inoculation onto GF-1 cells. Cells were grown in plug seal
cap culture vessels at 15°C in L-15 supplemented with 1%
L-glutamine (2 mM), 0.1% gentamicin sulphate (50 μgm l
-
1) (all from Sigma Aldrich, St. Louis, USA) and 10% fetal
bovine serum (Invitrogen, CA, USA). Cytopathic effect
(CPE) was evident by accumulation of cytoplasmic
vacuoles from 6 until 21 days post inoculation, when
supernatant and cell lysate were harvested. CPE was repro-
duced when passaged onto fresh cells. Inoculation of cells
with heart tissue homogenate prepared from healthy
Atlantic salmon (confirmed by histopathology, score 0)
did not give CPE. Tanks with control groups were injected
i.p. with the same dose of conditioned medium from unin-
fected cell culture prepared as described above. Both
PMCV and control inoculums were tested negative for sal-
monid alphavirus subtype 3, infectious pancreatic necrosis
virus, infectious salmon anaemia virus, piscine reovirus
and grouper nervous necrosis virus by qPCR.
An overview of samplings and analyses is given in Addi-
tional file 3. Tissues and blood were sampled at eight time
p o i n t s :2 ,4 ,6 ,8 ,9 ,1 0 ,1 1a n d1 2w p i ,i no r d e rt oc o v e r
early infection phase (biweekly sampling) and clinical
phase with improved coverage (weekly sampling). In addi-
tion, samples were taken from fish before the experiment
started (0 wpi). From each time point, 15 fish from each of
the four tanks were sedated (as described above) and
euthanized by decapitation. Standardised samples from
heart, mid-kidney, liver and spleen were snap-frozen in
liquid nitrogen for RNA, and fixed in formalin (10% neu-
tral phosphate-buffered) for histology. Blood was sampled
from the caudal vein in heparinized vacutainers and kept
on ice. Peripheral blood leukocytes (PBL) were separated
from red blood cells (RBC) as described [44] and stored at
-80°C until RNA was extracted.
Histopathology
Formalin-fixed heart samples were prepared by paraffin
wax embedding and standard histological techniques
[45]. Sections were stained with haematoxylin and eosin.
From each fish, a longitudinal section of the whole heart
was evaluated. All cardiac compartments were examined
and classified histologically using a visual analogue scale.
Atrium, epicardium, compact and spongy layers of the
ventricle were graded from 0 to 3 according to the
severity of the lesions [7]. Score 0 and 1 was considered
normal, with no histopathological findings (score 0), or
as i n g l eo rf e wf o c a ll e s i o n s( s c o r e1 ) .S c o r e2r e p r e -
sented several distinct lesions and increased mononuc-
lear infiltration. Score 3 represented multifocal to
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severe leukocyte infiltration. Sections were coded and
evaluation was randomised and blinded.
RNA extraction
Tissue samples for microarray hybridization and qPCR
were stored at -80°C prior to RNA extraction. Standar-
dised tissue sections of 10 mg from each organ and 5-
10 × 10
6 blood cells (PBL and RBC) were prepared
under sterile/RNase-free conditions. Tissue sections
from heart consisted of an equal mix of ventricle and
atrium with all compartments included. Frozen sections
were transferred directly to 1 ml chilled TRIzol (Invitro-
gen) in 2 ml tubes with screw caps (Precellys
®24, Bertin
Technologies, Orléans, France). Two steel beads (2 mm
diameter) were added to each tube and tissue was
homogenized in a Precellys
®24 homogenizer for two
times 25 sec at 5000 rounds per minute with a pause of
5 sec between rounds. Blood samples were homogenized
in 1 ml chilled TRIzol by repetitive pipetting up and
down. RNA was extracted from the homogenized tissues
using PureLink RNA Mini kits according to the protocol
for TRIzol-homogenised samples (Invitrogen). The con-
centration of extracted total RNA was measured with a
NanoDrop 1000 Spectrometer (Thermo Scientific, Wal-
tham, MA, USA). The integrity of total RNA was deter-
mined using an Agilent 2100 Bioanalyzer with RNA
Nano kits (Agilent Technologies, CA, USA). Samples
with RNA integrity number (RIN) of 8 or higher were
accepted.
Design of microarray experiments
An overview of microarray analyses is given in Addi-
tional file 3. The salmonid oligonucleotide microarray
(SIQ2.0, NCBI GEO platform GPL10679) was used, con-
sisting of 21 K features printed in duplicates on 4 × 44
K chips from Agilent Technologies [9]. Two-color
design was used, where pooled infected fish labelled
with fluorescent Cy5 dye and non-infected pooled con-
trol fish from the same time point labelled with Cy3 dye
were competitively hybridised on the array. Microarray
hybridizations were divided in two experimental lines.
The first was a time course study in heart tissue from 2,
4, 6, 8, 9 and 10 wpi. These time points were selected
based on the results from histopathological examination
(Figure 1), and covered the early infection phase and
peak of cardiac pathology. From each time point, biolo-
gical replicates of test (infected) samples consisted of
two RNA pools with each pool consisting of three indi-
vidual fish. For time points 4 and 8 wpi, representing
respectively the early and clinical phase of infection, two
new pools were added, each consisting of two fish (dif-
ferent than those used in the first two pools). The indi-
vidual fish were selected for maximum heart
histopathology score at the time points when this was
significant (from 6 wpi onwards, see Figure 1). Reference
samples were pooled RNA (equimolar amounts of total
RNA) from eight to ten fish from groups 1 and 2 (non-
infected controls) per each time point. The second
experimental line focused on tissue responses in mid-
kidney, liver, spleen, PBL and RBC (in addition to heart
as described above) at the early and clinical phase of
infection, respectively 4 and 8 wpi. Similar to the time
course study, biological replicates were two pools of
RNA, each consisting of three individual fish, per each
tissue and time point. The two pools were RNA from
t h es a m es i xi n d i v i d u a l sa su s e df o rt h et i m ec o u r s e
study. Reference sample pools were prepared in the
same manner, with RNA from the same non-infected
control individuals as used for the time course study.
Recording of microarray experiment metadata was in
compliance with the Minimum Information About a
Microarray Experiment (MIAME) guidelines [46].
Microarray hybridization and data processing
Unless specified otherwise, all reagents and equipment
used for microarray analyses were from Agilent Tech-
nologies according to manufacturer’s protocol. Labelling
and amplification of RNA was performed on 500 ng
total RNA using Quick Amp Labeling Kits, Two-Color
and RNA Spike-In Kits, Two-Color. For fragmentation
of labelled RNA, the Gene Expression Hybridization Kit
was used. Hybridizations were performed for 17 hours
in an Agilent hybridization oven set to 65°C with a rota-
tion speed of 10 rounds per minute. Arrays were washed
for one minute with Gene Expression Wash Buffer I at
room temperature, and one minute with Gene Expres-
sion Wash Buffer II at 37°C. Slides were scanned imme-
diately after washing using a GenePix Personal 4100 A
scanner (Molecular Devices, Sunnyvale, CA, USA) at 5
μm resolution and with manually adjusted laser power
to ensure an overall intensity ratio close to unity
between Cy3 and Cy5 channels and with minimal
saturation of features. The GenePix Pro software (ver-
sion 6.1) was used for spot-grid alignment, feature
extraction of fluorescence intensity values and assess-
ment of spot quality. After filtration of low quality
spots, data were exported into the STARS platform [9]
for data transformation, normalization and quality filter-
ing. The values in spot replicates were averaged, Lowess
normalization of log2-expression ratios (ER) was per-
formed, and differentially expressed genes (DEG) were
selected based on mean log2-ER > |0.65| in at least one
time point and tissue, spot signal quality threshold,
number of positive spots and one-sample t- t e s t( p<
0.05, H0:l o g 2-ER = 0). Corrections for false discovery
rate were not employed as previous microarray studies
in Atlantic salmon have demonstrated them to be overly
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further analysis included 5712 genes. Data was sub-
mitted to GEO (submission number GSE28843).
Gene sets and annotations
For this work, functional subgroups or gene sets were
compiled from the list of 5712 differentially expressed
genes (Additional file 1). These were created by the use
of the STARS software package customized for mining
of microarray gene expression data [9]. STARS contain
custom annotations of genes on the microarray based
on GO classes, KEGG pathways, mining of literature
and public databases and experimental evidence (tran-
scription profiles/meta-analyses).
Quantitative real-time RT-PCR
The following section relates to the analysis of host
gene expression. Experiments were conducted accord-
ing to the MIQE guidelines [49]. Synthesis of cDNA
was performed on 0.2 μgD N A s e - t r e a t e dt o t a lR N A
(Turbo DNA-freeTM, Ambion, Austin, TX, USA)
using the TaqMan
® Gold Reverse Transcription kit
(Applied Biosystems, Foster City, CA, USA) in 25 μl
reactions with random hexamer priming according to
manufacturer’s protocol. Complementary DNA was
stored undiluted at -80°C in aliquots to avoid repeated
freeze-thawing. To avoid risk for presence of residual
DNA contamination, control reactions without RT was
tested on respective tissues and qPCR primers were
possibly designed to span introns. Oligonucleotide pri-
mers were designed with the program eprimer3 from
the EMBOSS program package (version 5.0.0, http://
emboss.sourceforge.net/). Amplicon size was set to 80-
160 and melting temperature to 59-61°C. Primers were
p u r c h a s e df r o mI n v i t r o g e n (Additional file 4). In silico
analysis of gene targets was performed using a custo-
mised program for BLAST and sequence alignments
[9]. PCR amplicon size and specificity were confirmed
by gel electrophoresis and melting curve analysis (Tm
calling; LightCycler 480, Roche Diagnostics, Mannheim,
Germany). QPCR was conducted using 2× SYBR
®
Green Master Mix (Roche Diagnostics) in an optimised
12 μl reaction volume, using 5 μl of 1:10 diluted
cDNA, and primer concentrations of 0.42 μM. PCR
reactions were prepared manually and run in duplicates
in 96-well optical plates on a Light Cycler 480 (Roche
Diagnostics) with the following conditions: 95°C for 5
min (pre-incubation), 95°C for 5 sec, 60°C for 15 sec,
72°C for 15 sec (amplification, 45 cycles) and continu-
o u si n c r e a s ef r o m6 5 ° Ct o9 7 ° Cw i t hs t a n d a r dr a m p
rate (melting curve). Cycle threshold (CT) values were
calculated using the second derivative method. For eva-
luation of the results, the mean of duplicates was used.
Duplicate measurements that differed more than 0.5
CT values were removed and reanalysed. Relative
expression ratios of test samples versus the average of
the controls were calculated according to [50]. Elonga-
tion factor 1a (GenBank ID: BT072490.1) was used as
r e f e r e n c eg e n e[ 5 1 ] ,a n dw a sf o u n dt ob es t a b l yt r a n -
scribed in control and test samples according to the
BestKeeper software [52]. The efficiency of the PCR
reactions was estimated for all primer pairs by six
times 1:5 dilution series of a cDNA mix of all used
samples. The efficiency values were estimated by using
the LightCycler
® 480 Software (version 1.5.0.39). All
measured efficiencies were between 1.905 and 1.999.
Viral load
Relative quantification of PMCV was employed by qPCR
on RNA isolated as described above from selected sam-
ples (heart; weeks 0, 2, 4, 6, 8, 9, 10, 11, 12, n = 6, kid-
ney/liver/spleen/PBL/RBC; weeks 4 and 8, n = 6). Each
sample’s RNA concentration was normalized to 62.5 ng
per 20 μl cDNA synthesis reaction, which was part of
the SuperScript
® III Platinum
® Two-Step qRT-PCR Kit
with SYBR
® Green (Invitrogen). In order to reduce sec-
ondary structures, RNA was heat denatured at 95°C - 5
min and then cooled down to 4°C prior to addition of
RT enzyme and master mix. cDNA synthesis reaction
conditions and temperature cycling were kept in line
with manufacturer’s guidelines. qPCR was performed on
each sample in triplicate reactions containing 12.5 μl2 ×
Platinum
® SYBR
® Green qPCR SuperMix-UDG, ROX
reference dye was added to the master mix to give a
final reaction concentration of 50 nM, 1.25 μl6μM
ORF2-3F (5’-GGAAGCAGAAGTGGTGGAGCGT-3’)
and 1.25 μl6μM ORF2-3R (5’-CCGGTTTTGCG
CCCTTCGTC-3’). Ten μl 1:10 dilution of cDNA was
added per reaction. The reaction conditions were UDG-
incubation at 50°C for 2 min, activation of the hot-start
polymerase at 95°C for 2 min, followed by 45 cycles of
95°C for 15 sec, primer annealing for 15 sec and exten-
sion for 45 sec at 60°C. Melting curve analysis was per-
formed to confirm formation of expected amplicon. The
viral loads were expressed as a relative copy number
with non-infected controls (0 wpi) set to 1, calculated
by the formula 2^(CT(0wpi median)-C T(sample)).
Statistical analyses
Histopathology scores and pair-wise comparison of gene
sets were tested for significant differences by an inde-
pendent two-sample t test using the function t-test() in
the R software STATS-package (version 2.10.1, http://
www.cran.r-project.org/). In addition, one-way ANOVA
followed by Newman-Keuls test was used to assess dif-
ferences between time points and tissues for each gene
set. Correlations and respective p-values were calculated
by the cor.test() function in R. For all tests, significance
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Page 15 of 17levels of the resulting p-values with p < 0.05 and p >
0.01 are marked with single asterisk (*), and p < 0.01 are
marked with double asterisk (**) in all figures. The func-
tion of the regression line and the respective p-value for
the confirmation of the microarray experiments by
qPCR were calculated by the lm()-function ("linear
model”)i nR .
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composition and respective log2-ER for the six gene sets representing
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